These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 14577833

  • 1. Early events in ovarian oncogenesis.
    Cvetkovic D.
    Reprod Biol Endocrinol; 2003 Oct 07; 1():68. PubMed ID: 14577833
    [Abstract] [Full Text] [Related]

  • 2. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
    Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC.
    J Cell Biochem; 2007 Dec 01; 102(5):1117-29. PubMed ID: 17879946
    [Abstract] [Full Text] [Related]

  • 3. Models of ovarian cancer--are we there yet?
    Garson K, Shaw TJ, Clark KV, Yao DS, Vanderhyden BC.
    Mol Cell Endocrinol; 2005 Jul 15; 239(1-2):15-26. PubMed ID: 15955618
    [Abstract] [Full Text] [Related]

  • 4. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

  • 5. Gene expression profiling of ovarian tissues for determination of molecular pathways reflective of tumorigenesis.
    Mougeot JL, Bahrani-Mostafavi Z, Vachris JC, McKinney KQ, Gurlov S, Zhang J, Naumann RW, Higgins RV, Hall JB.
    J Mol Biol; 2006 Apr 21; 358(1):310-29. PubMed ID: 16503337
    [Abstract] [Full Text] [Related]

  • 6. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD, Petrescu A, Waller M, Dina I.
    Rom J Morphol Embryol; 2008 Apr 21; 49(3):327-38. PubMed ID: 18758637
    [Abstract] [Full Text] [Related]

  • 7. The biology of ovarian cancer of epithelial origin.
    Rabinerson D, Kaplan B, Levavi H, Neri A.
    Isr J Med Sci; 1996 Nov 21; 32(11):1128-33. PubMed ID: 8960089
    [Abstract] [Full Text] [Related]

  • 8. Advances in the management of epithelial ovarian cancer.
    Berkenblit A, Cannistra SA.
    J Reprod Med; 2005 Jun 21; 50(6):426-38. PubMed ID: 16050567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Biological characteristics of an established model of ovarian cancer in mice and its homologous cell lines].
    Zhang ZM, Zhang C, Zhang FH, Shan BE, Nakagawa S.
    Ai Zheng; 2006 Jun 21; 25(6):701-7. PubMed ID: 16764764
    [Abstract] [Full Text] [Related]

  • 11. The hamster model of sequential oral oncogenesis.
    Vairaktaris E, Spyridonidou S, Papakosta V, Vylliotis A, Lazaris A, Perrea D, Yapijakis C, Patsouris E.
    Oral Oncol; 2008 Apr 21; 44(4):315-24. PubMed ID: 18061531
    [Abstract] [Full Text] [Related]

  • 12. Endometriosis and ovarian cancer: clinical and molecular aspects.
    Pavlidou A, Vlahos NF.
    Minerva Endocrinol; 2014 Sep 21; 39(3):155-65. PubMed ID: 25003226
    [Abstract] [Full Text] [Related]

  • 13. Molecular dissection of multi-stage tumorigenesis in transgenic mice.
    Christofori G, Hanahan D.
    Semin Cancer Biol; 1994 Feb 21; 5(1):3-12. PubMed ID: 8186386
    [Abstract] [Full Text] [Related]

  • 14. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
    Williams TI, Toups KL, Saggese DA, Kalli KR, Cliby WA, Muddiman DC.
    J Proteome Res; 2007 Aug 21; 6(8):2936-62. PubMed ID: 17583933
    [Abstract] [Full Text] [Related]

  • 15. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F, Codegoni A, Fruscio R, Perego P, Mangioni C, Saha S, Bardelli A, Broggini M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [Abstract] [Full Text] [Related]

  • 16. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis.
    Simon R, Desper R, Papadimitriou CH, Peng A, Alberts DS, Taetle R, Trent JM, Schäffer AA.
    Genes Chromosomes Cancer; 2000 May 01; 28(1):106-20. PubMed ID: 10738309
    [Abstract] [Full Text] [Related]

  • 17. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
    Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y.
    Curr Opin Obstet Gynecol; 2007 Feb 01; 19(1):3-9. PubMed ID: 17218844
    [Abstract] [Full Text] [Related]

  • 18. Rules of tumor cell development and their application to biomarkers for ovarian cancer.
    McLemore MR, Miaskowski C, Aouizerat BE, Chen LM, Dodd M.
    Oncol Nurs Forum; 2008 May 01; 35(3):403-9. PubMed ID: 18467290
    [Abstract] [Full Text] [Related]

  • 19. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression.
    Peters DG, Kudla DM, Deloia JA, Chu TJ, Fairfull L, Edwards RP, Ferrell RE.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 01; 14(7):1717-23. PubMed ID: 16030107
    [Abstract] [Full Text] [Related]

  • 20. Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions.
    David S, Meltzer SJ.
    Cancer Biomark; 2010 Jul 01; 9(1-6):493-507. PubMed ID: 22112492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.